Literature DB >> 28192107

Gastrointestinal Complications of Obesity.

Michael Camilleri1, Harmeet Malhi2, Andres Acosta2.   

Abstract

Obesity usually is associated with morbidity related to diabetes mellitus and cardiovascular diseases. However, there are many gastrointestinal and hepatic diseases for which obesity is the direct cause (eg, nonalcoholic fatty liver disease) or is a significant risk factor, such as reflux esophagitis and gallstones. When obesity is a risk factor, it may interact with other mechanisms and result in earlier presentation or complicated diseases. There are increased odds ratios or relative risks of several gastrointestinal complications of obesity: gastroesophageal reflux disease, erosive esophagitis, Barrett's esophagus, esophageal adenocarcinoma, erosive gastritis, gastric cancer, diarrhea, colonic diverticular disease, polyps, cancer, liver disease including nonalcoholic fatty liver disease, cirrhosis, hepatocellular carcinoma, gallstones, acute pancreatitis, and pancreatic cancer. Gastroenterologists are uniquely poised to participate in the multidisciplinary management of obesity as physicians caring for people with obesity-related diseases, in addition to their expertise in nutrition and endoscopic interventions.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Fat; Gallbladder; Liver; Pancreas

Mesh:

Year:  2017        PMID: 28192107      PMCID: PMC5609829          DOI: 10.1053/j.gastro.2016.12.052

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  165 in total

Review 1.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

Authors:  Siddharth Singh; Alina M Allen; Zhen Wang; Larry J Prokop; Mohammad H Murad; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

2.  Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

3.  Gallbladder pathology in morbid obesity.

Authors:  George W Dittrick; Jon S Thompson; Daniel Campos; Doug Bremers; Debra Sudan
Journal:  Obes Surg       Date:  2005-02       Impact factor: 4.129

4.  Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop.

Authors:  Adil E Bharucha; Gena Dunivan; Patricia S Goode; Emily S Lukacz; Alayne D Markland; Catherine A Matthews; Louise Mott; Rebecca G Rogers; Alan R Zinsmeister; William E Whitehead; Satish S C Rao; Frank A Hamilton
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

Review 5.  Obesity and colorectal cancer.

Authors:  Marc Bardou; Alan N Barkun; Myriam Martel
Journal:  Gut       Date:  2013-03-12       Impact factor: 23.059

Review 6.  Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD).

Authors:  Stefano Bellentani; Mariano Marino
Journal:  Ann Hepatol       Date:  2009       Impact factor: 2.400

7.  Effect of obesity on gastroesophageal resistance to flow in man.

Authors:  P Zacchi; F Mearin; P Humbert; X Formiguera; J R Malagelada
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

8.  Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.

Authors:  Catherine Duggan; Lynn Onstad; Sheetal Hardikar; Patricia L Blount; Brian J Reid; Thomas L Vaughan
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-01       Impact factor: 11.382

9.  The effects of obesity on oesophageal function, acid exposure and the symptoms of gastro-oesophageal reflux disease.

Authors:  R Anggiansah; R Sweis; A Anggiansah; T Wong; D Cooper; M Fox
Journal:  Aliment Pharmacol Ther       Date:  2013-01-10       Impact factor: 8.171

10.  An association between colonic adenoma and abdominal obesity: a cross-sectional study.

Authors:  Youngjoo Kim; Yunjin Kim; Sangyeoup Lee
Journal:  BMC Gastroenterol       Date:  2009-01-15       Impact factor: 3.067

View more
  39 in total

1.  Obesity management for the gastroenterologist.

Authors:  Saleem Ansari; Hasan Haboubi; Nadim Haboubi
Journal:  Frontline Gastroenterol       Date:  2020-04-27

2.  Increased Risk for Colon Polyps in Patients with Reflux Disease.

Authors:  Amnon Sonnenberg; Kevin O Turner; Robert M Genta
Journal:  Dig Dis Sci       Date:  2017-11-17       Impact factor: 3.199

3.  Obesity is associated with significantly increased risk for diarrhoea after controlling for demographic, dietary and medical factors: a cross-sectional analysis of the 2009-2010 National Health and Nutrition Examination Survey.

Authors:  Sarah Ballou; Prashant Singh; Vikram Rangan; Johanna Iturrino; Judy Nee; Anthony Lembo
Journal:  Aliment Pharmacol Ther       Date:  2019-09-18       Impact factor: 8.171

4.  Phenome-wide screening of GWAS data reveals the complex causal architecture of obesity.

Authors:  Luis M García-Marín; Adrián I Campos; Pik-Fang Kho; Nicholas G Martin; Gabriel Cuéllar-Partida; Miguel E Rentería
Journal:  Hum Genet       Date:  2021-05-31       Impact factor: 4.132

5.  Risk of gallstones in patients with obstructive sleep apnea: a nationwide observational cohort study.

Authors:  Chien-Hua Chen; Cheng-Li Lin; Chung-Y Hsu; Chia-Hung Kao
Journal:  Sleep Breath       Date:  2018-07-07       Impact factor: 2.816

Review 6.  Neutrophil Extracellular Traps and Liver Disease.

Authors:  Moira B Hilscher; Vijay H Shah
Journal:  Semin Liver Dis       Date:  2019-11-14       Impact factor: 6.115

7.  Relationship between Barrett's esophagus and colonic diseases: a role for colonoscopy in Barrett's surveillance.

Authors:  Yuji Amano; Ryotaro Nakahara; Takafumi Yuki; Daisuke Murakami; Tetsuro Ujihara; Iwaki Tomoyuki; Ryota Sagami; Satoshi Suehiro; Yasushi Katsuyama; Kenji Hayasaka; Hideaki Harada; Yasumasa Tada; Youichi Miyaoka; Hirofumi Fujishiro
Journal:  J Gastroenterol       Date:  2019-06-25       Impact factor: 7.527

Review 8.  Lesions in the oral cavity and esophagus caused by prescribed drugs: A review.

Authors:  Snezana Tesic-Rajkovic; Biljana Radovanovic-Dinic
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-11-05       Impact factor: 1.245

9.  Magnesium intake is inversely associated with risk of obesity in a 30-year prospective follow-up study among American young adults.

Authors:  Liping Lu; Cheng Chen; Kefeng Yang; Jie Zhu; Pengcheng Xun; James M Shikany; Ka He
Journal:  Eur J Nutr       Date:  2020-02-24       Impact factor: 5.614

10.  FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis.

Authors:  Tianli Chen; Hongda Liu; Zengli Liu; Kangshuai Li; Ruixi Qin; Yue Wang; Jialiang Liu; Zhipeng Li; Qinglun Gao; Chang Pan; Fan Yang; Wei Zhao; Zongli Zhang; Yunfei Xu
Journal:  Oncogene       Date:  2021-06-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.